Genomic changes in regenerated porcine coronary arterial endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 11, 2007, Pages 2443-2449

  Lee, Mary Y K ^a   Tse, Hung Fat ^a   Siu, Chung Wah ^a   Zhu, Shu Guang ^a   Man, Ricky Y K ^a   Vanhoutte, Paul M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Coagulation; Endothelial regeneration; Extracellular matrix; Genomics; Lipids; Nitric oxide; ROS

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANGIOTENSIN 2 RECEPTOR; BRADYKININ; CALCIMYCIN; CYCLIC GMP; CYCLOOXYGENASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID BINDING PROTEIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; MANGANESE SUPEROXIDE DISMUTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PHOSPHOLIPASE A2; PROTHROMBIN; THIOREDOXIN REDUCTASE; TISSUE FACTOR PATHWAY INHIBITOR;

ADIPOCYTE; ADRENERGIC SYSTEM; ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTERY DISSECTION; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON; BLOOD CLOTTING; CELL PROLIFERATION; CELL REGENERATION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CIRCUMFLEX BRANCH; DOWN REGULATION; ELECTRODERMAL RESPONSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME ANALYSIS; GROWTH REGULATION; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID METABOLISM; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; SWINE; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CORONARY BLOOD VESSEL; DNA MICROARRAY; GENETICS; INJURY; METABOLISM; PHYSIOLOGY; REGENERATION;

ANIMALS; CELLS, CULTURED; CORONARY VESSELS; CYCLIC GMP; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; LIPID METABOLISM; MATRIX METALLOPROTEINASE 7; NITRIC OXIDE SYNTHASE TYPE III; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REGENERATION; RNA, MESSENGER; SUS SCROFA; THIOREDOXIN REDUCTASE (NADPH);

EID: 36048970965     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.141705     Document Type: Article

References (57)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
3. Moncada S, Vane JR. Prostacyclin and its clinical applications. Ann Clin Res. 1984;16:241-252.
4. Vanhoutte PM. Endothelial dysfunction and vascular disease. In Endothelium, Nitric Oxide and Atherosclerosis. 1999. Panza JA, Cannon RO III. New York: Futura Publishing Co, Inc, Armonk. 79-95.
5. Vanhoutte PM. Endothelial control of vasomotor function: from health to coronary disease. Circ J. 2003;67:572-575.
6. Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 1987;61:256-270.
7. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res. 1989;65:740-753.
8. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89:2429-2442.
9. Lüscher TF, Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis. 1995;118(suppl):S81-S90.
10. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest. 1996;98:899-905.
11. Fournet-Bourguignon MP, Castedo-Delrieu M, Bidouard JP, Leonce S, Saboureau D, Delescluse I, Vilaine JP, Vanhoutte PM. Phenotypic and functional changes in regenerated porcine coronary endothelial cells: increased uptake of modified LDL and reduced production of NO. Circ Res. 2000;86:854-861.
12. Kennedy S, Fournet-Bourguignon MP, Breugnot C, Castedo-Delrieu M, Lesage L, Reure H, Briant C, Leonce S, Vilaine JP, Vanhoutte PM. Cells derived from regenerated endothelium of the porcine coronary artery contain more oxidized forms of apolipoprotein-B-100 without a modification in the uptake of oxidized LDL. J Vasc Res. 2003;40:389-398.
13. Borg-Capra C, Fournet-Bourguignon MP, Janiak P, Villeneuve N, Bidouard JP, Vilaine JP, Vanhoutte PM. Morphological heterogeneity with normal expression but altered function of G proteins in porcine cultured regenerated coronary endothelial cells. Br J Pharmacol. 1997;122:999-1008.
14. Braam B, de Roos R, Dijk A, Boer P, Post JA, Kemmeren PP, Holstege FC, Bluysen HA, Koomans HA. Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells. Am J Physiol Heart Circ Physiol. 2004;287:H1977-H1986.
15. Rose'Meyer RB, Mellick AS, Garnham BG, Harrison GJ, Massa HM, Griffiths LR. The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc. 2003;11:9-18.
16. Fisslthaler B, Benzing T, Busse R, Fleming I. Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. Nitric Oxide. 2003;8:253-261.
17. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004;117:2417-2426.
18. de Smet BJ, van der Zande J, van der Helm YJ, Kuntz RE, Borst C, Post MJ. The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling. Cardiovasc Res. 1998;39:224-232.
19. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res. 2004;95:343-353.
20. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation. 2004;110:2039-2046.
21. Fonseca FA, Izar MC, Fuster V, Gallo R, Padurean A, Fallon JT, Schachter EN, Chesebro JH, Badimon JJ. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro. Atherosclerosis. 2001;154:61-69.
22. Schober A, Karshovska E, Zernecke A, Weber C. SDF-1α-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc Med. 2006;16:103-108.
23. Serrano CV Jr, Rocha Giraldez R, de Lara Fernandes J, Nicolau JC, Zweier JL, Ramires JA. Platelet and leukocyte adhesion and activation in unstable angina and post-PTCA. Int J Cardiol. 2005;99:423-428.
24. Hunting CB, Noort WA, Zwaginga JJ. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization. Vox Sang. 2005;88:1-9.
25. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest. 2006;116:1284-1291.
26. Hartell NA, Archer HE, Bailey CJ. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol. 2005;69:781-790.
27. Ryoo S, Lemmon CA, Soucy KG, Gupta G, White AR, Nyhan D, Shoukas A, Romer LH, Berkowitz DE. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res. 2006;99:951-960.
28. Boulanger CM, Vanhoutte PM. G proteins and endothelium-dependent relaxations. J Vasc Res. 1997;34:175-185.
29. De Gennaro Colonna V, Fioretti S, Rigamonti A, Bonomo S, Manfredi B, Muller EE, Berti F, Rossoni G. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism. J Hypertens. 2006;24:95-102.
30. Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens. 2007;21:20-27.
31. Vanhoutte PM. Say NO to ET. J Auton Nerv Syst. 2000;81:271-277.
32. Vane JR, Botting RM Pharmacodynamic profile of prostacyclin. Am J Cardiol. 1995;75:3A-10A.
33. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007;100:460-473.
34. Droge W. Free radicals in the physiological control of cell functions. PhysiolRev. 2001;82:47-95.
35. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1014-R1030.
36. Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br J Pharmacol. 2005;144:449-458.
37. Zhang Y, Handy DE, Loscalzo J. Adenosine-dependent induction of glutathione peroxidase 1 in human primary endothelial cells and protection against oxidative stress. Circ Res. 2005;96:831-837.
38. Fu Y, Luo N, Lopes-Virella MF, Garvey WT. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis. 2002;165:259-269.
39. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447:959-965.
40. Kadl A, Leitinger N. The role of endothelial cells in the resolution of acute inflammation. Antioxid Redox Signal. 2005;7:1744-1754.
41. McMahon B, Godson C. Lipoxins: endogenous regulators of inflammation. Am J Physiol Renal Physiol. 2004;286:F189-F201.
42. Exil VJ, Roberts RL, Sims H, McLaughlin JE, Malkin RA, Gardner CD, Ni G, Rottman JN, Strauss AW. Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ Res. 2003;93:448-455.
43. Bostrom P, Magnusson B, Svensson PA, Wiklund O, Boren J, Carlsson LM, Stahlman M, Olofsson SO, Hulten LM. Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol. 2006;26:1871-1876.
44. Kharbanda RK, Wallace S, Walton B, Donald A, Cross JM, Deanfield J. Systemic Acyl-CoA:cholesterol acyltransferase inhibition reduces inflammation and improves vascular function in hypercholesterolemia. Circulation. 2005;111:804-807.
45. Cavelier C, Rohrer L, von Eckardstein A. ATP-binding cassette transporter A1 modulates apolipoprotein A-1 transcytosis through aortic endothelial cells. Circ Res. 2006;99:1060-1066.
46. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.
47. Horie S, Hiraishi S, Hirata Y, Kazama M, Matsuda J. Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells. Biochem J. 2000;352:277-285.
48. Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest. 1994;93:2073-2083.
49. Yang YM, Moussa I. Percutaneous coronary intervention and drug-eluting stents. CMAJ. 2005;172:323-325.
50. Nakatani M, Takeyama Y, Shibata M, Yorozuya M, Suzuki H, Koba S, Katagiri T. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting. Cardiovasc Pathol. 2003;12:40-48.
51. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res. 2001;89:201-210.
52. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A. 1996;93:9748-9753.
53. Garcia-Touchard A, Henry TD, Sangiorgi G, Spagnoli LG, Mauriello A, Conover C, Schwartz RS. Extracellular Proteases in Atherosclerosis and Restenosis. Arterioscler Thromb Vasc Biol. 2005;25:1119-1127.
54. Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-β1 in intimal thickening after vascular injury. Cardiovasc Res. 2007;74:223-234.
55. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
56. Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, Weitz JI, Austin RC. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood. 1999;94:959-967.
57. Chong AY, Caine GJ, Lip GYH. Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure? Eur J Clin Invest. 2004;34:9-13.